Histamine H3 receptor antagonists

Details for Australian Patent Application No. 2006264966 (hide)

Owner Novo Nordisk A/S

Inventors Sorensen, Jan Lindy; Andersen, Knud Erik; Hohlweg, Rolf; Lundbeck, Jane Marie

Agent Shelston IP

Pub. Number AU-A-2006264966

PCT Pub. Number WO2007/003604

Priority 05109674.1 18.10.05 EP; 05106038.2 04.07.05 EP; 05106037.4 04.07.05 EP; 06114615.5 29.05.06 EP

Filing date 30 June 2006

Wipo publication date 11 January 2007

International Classifications

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/444 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 213/84 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/87 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 241/20 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/08 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/003604 Priority application(s): WO2007/003604

31 July 2008 Assignment before Grant

  Novo Nordisk A/S The application has been assigned to TransTech Pharma, Inc. Assignments before Grant, Section 113

19 February 2009 Assignment before Grant

  TransTech Pharma, Inc. The application has been assigned to High Point Pharmaceuticals, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006264979-Process to prepare a mineral derived residual deasphalted oil blend

2006264958-2,4-diamino-pyrimidines used as aurora inhibitors